Morphea-like Skin Lesions Reported in the Phase 3 Long-Term Odanacatib Fracture Trial and Extension in Postmenopausal Women with Osteoporosis

被引：0
|
作者：
Saag, Kenneth G. [1 ]
de Villiers, Tobie [2 ,3 ]
Alexandersen, Peter [4 ]
Jacobe, Heidi [5 ]
Kovarik, Carrie [6 ]
Werth, Victoria P. [7 ]
Leung, Albert [8 ]
Desai-Merchant, Avani [8 ]
Mattaliano, Julie [8 ]
Gurner, Deborah [8 ]
机构：
[1] Univ Alabama Birmingham, Dept Med, Div Rheumatol & Immunol, Birmingham, AL 35294 USA
[2] Univ Stellenbosch, Mediclin Panorama, Cape Town, South Africa
[3] Univ Stellenbosch, Dept Obstet & Gynecol, Cape Town, South Africa
[4] Ctr Clin & Basic Res, Vejle, Denmark
[5] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA
[6] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[7] Philadelphia VAMC, Philadelphia, PA USA
[8] Merck & Co Inc, Kenilworth, NJ USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1026
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Morphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis
    Saag, Kenneth G.
    de Villiers, Tobias J.
    Alexandersen, Peter
    Jacobe, Heidi
    Kovarik, Carrie
    Werth, Victoria P.
    Leung, Albert
    Desai-Merchant, Avani
    Mattaliano, Julie
    Gurner, Deborah
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (04) : 1113 - 1119
  • [2] Odanacatib Efficacy and Safety in Postmenopausal Women with Osteoporosis: 5-Year Data from the Extension of the Phase 3 Long-Term Odanacatib Fracture Trial
    McClung, Michael R.
    Langdahl, Bente
    Papapoulos, Socrates
    Saag, Kenneth G.
    Bone, Henry
    Kiel, Douglas P.
    Lippuner, Kurt
    Nakamura, Toshitaka
    Reid, Ian
    Heyden, Norman
    DaSilva, Carolyn
    Scott, Boyd B.
    Massaad, Rachid
    Kaufman, Keith D.
    Stoch, Aubrey
    Santora, Arthur
    Gurner, Deborah
    Lombardi, Antonio
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [3] Efficacy of Odanacatib in Postmenopausal Women with Osteoporosis: Subgroup Analyses of Data from the Phase 3 Long-Term Odanacatib Fracture Trial
    Saag, Kenneth G.
    Alexandersen, Peter
    Benhamou, Claude-Laurent
    Gilchrist, Nigel
    Halse, Johan
    Lewiecki, E. Michael
    Lippuner, Kurt
    McClung, Michael
    Shiraki, Masataka
    DaSilva, Carolyn A.
    Verbruggen, Nadia
    Scott, Boyd B.
    Lombardi, Antonio
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] Odanacatib Efficacy and Safety in Postmenopausal Women with Osteoporosis: 5-Year Data from the Extension of the Phase 3 Long-term Odanacatib Fracture Trial (LOFT)
    McClung, Michael R.
    Langdahl, Bente
    Papapoulos, Socrates
    Saag, Kenneth G.
    Bone, Henry
    Kiel, Douglas P.
    Lippuner, Kurt
    Nakamura, Toshitaka
    Reid, Ian
    Heyden, Norman
    DaSilva, Carolyn
    Scott, Boyd B.
    Massaad, Rachid
    Kaufman, Keith D.
    Stoch, S. Aubrey
    Santora, Arthur
    Gurner, Deborah
    Lombardi, Antonio
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (12): : 1369 - 1369
  • [5] EFFICACY OF ODANACATIB IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: SUBGROUP ANALYSES OF DATA FROM THE PHASE 3 LONG-TERM ODANACATIB FRACTURE TRIAL (LOFT)
    Saag, K. G.
    Alexandersen, P.
    Benhamou, C. -L.
    Gilchrist, N.
    Halse, J.
    Lewiecki, E. M.
    Lippuner, K.
    McClung, M.
    Shiraki, M.
    DaSilva, C. A.
    Verbruggen, N.
    Scott, B. B.
    Lombardi, A.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S50 - S51
  • [6] SAFETY AND TOLERABILITY OF ODANACATIB THERAPY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE PHASE III LONG-TERM ODANACATIB FRACTURE TRIAL
    Papapoulos, S.
    McClung, M. R.
    Langdahl, B.
    Saag, K. G.
    Adami, S.
    Bone, H. G.
    de Villiers, T.
    Kiel, D. P.
    Kung, A.
    Kumar, P.
    Lim, S. -K.
    Ling, X.
    Lippuner, K.
    Mautalen, C.
    Nakamura, T.
    Reginster, J. -Y.
    Reid, I. R.
    Rodriguez-Portales, J. A.
    Roux, C.
    Walliser, J.
    Watts, N. B.
    Zanchetta, J.
    Zerbini, C. A.
    Rybak-Feiglin, A.
    Cohn, D.
    DaSilva, C. A.
    De Tilleghem, C. Le Bailly
    Santora, A.
    Scott, B. B.
    Verbruggen, N.
    Leung, A.
    Lombardi, A.
    Gurner, D.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : 604 - 605
  • [7] Odanacatib Anti-Fracture Efficacy and Safety in Postmenopausal Women with Osteoporosis: Results from the Phase III Long-Term Odanacatib Fracture Trial
    McClung, Michael R.
    Langdahl, Bente
    Papapoulos, Socrates
    Saag, Kenneth G.
    Adami, Silvano
    Bone, Henry G.
    de Villiers, Tobias
    Kiel, Douglas P.
    Kung, Annie
    Kumar, Prasanna
    Lim, Sung-Kil
    Ling, Xu
    Lippuner, Kurt
    Mautalen, Carlos
    Nakamura, Toshitaka
    Reginster, Jean-Yves
    Reid, Ian R.
    Adolfo Rodriguez-Portales, Jose
    Roux, Christian
    Walliser, Jesus
    Watts, Nelson B.
    Zanchetta, Jose R.
    Zerbini, Cristiano A. F.
    Rybak-Feiglin, Andrea
    Cohn, Dosinda
    DaSilva, Carolyn A.
    Massaad, Rachid
    Santora, Arthur
    Scott, Boyd B.
    Verbruggen, Nadia
    Leung, Albert
    Lombardi, Antonio
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S987 - S987
  • [8] ODANACATIB ANTI-FRACTURE EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE PHASE III LONG-TERM ODANACATIB FRACTURE TRIAL
    McClung, M. R.
    Langdahl, B.
    Papapoulos, S.
    Saag, K. G.
    Adami, S.
    Bone, H. G.
    de Villiers, T.
    Kiel, D. P.
    Kung, A.
    Kumar, P.
    Lim, S. -K.
    Ling, X.
    Lippuner, K.
    Mautalen, C.
    Nakamura, T.
    Reginster, J. -Y.
    Reid, I. R.
    Rodriguez-Portales, J. A.
    Roux, C.
    Walliser, J.
    Watts, N. B.
    Zanchetta, J.
    Zerbini, C. A.
    Rybak-Feiglin, A.
    Cohn, D.
    DaSilva, C. A.
    Massaad, R.
    Santora, A.
    Scott, B. B.
    Verbruggen, N.
    Leung, A.
    Lombardi, A.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : 573 - 575
  • [9] Safety and Tolerability of Odanacatib Therapy in Postmenopausal Women with Osteoporosis: Results from the Phase III Long-Term Odanacatib Fracture Trial (LOFT).
    Papapoulos, Socrates
    McClung, Michael
    Langdahl, Bente
    Saag, Kenneth
    Adami, Silvano
    Bone, Henry
    de Villiers, Tobias
    Kiel, Douglas
    Kung, Annie
    Kumar, Prasanna
    Lim, Sung-Kil
    Ling, Xu
    Lippuner, Kurt
    Mautalen, Carlos
    Nakamura, Toshitaka
    Reginster, Jean-Yves
    Reid, Ian
    Adolfo Rodriguez-Portales, Jose
    Roux, Christian
    Walliser, Jesus
    Watts, Nelson
    Ruben Zanchetta, Jose
    Zerbini, Christiano A. F.
    Fybak-Feiglin, Andrea
    Cohn, Dosinda
    da Silva, Carolyn A.
    De Tilleghem, Celine Le Bailly
    Santora, Arthur
    Scott, Boyd
    Verbruggen, Nadia
    Leung, Albert
    Lombardi, Antonio
    Gurner, Deborah
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S51 - S51
  • [10] ODANACATIB ANTIFRACTURE EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE PHASE III LONG-TERM ODANACATIB FRACTURE TRIAL (LOFT)
    McClung, M. R.
    Langdahl, B.
    Papapoulos, S.
    Saag, K. G.
    Adami, S.
    Bone, H. G.
    De Villiers, T.
    Kiel, D. P.
    Kung, A.
    Kumar, P. K. M.
    Lim, S. -K.
    Ling, X.
    Lippuner, K.
    Mautalen, C.
    Nakamura, T.
    Reginster, J. -Y.
    Reid, I. R.
    Rodriguez-Portales, A.
    Roux, C.
    Walliser, J.
    Watts, N. B.
    Zanchetta, J.
    Zerbini, C. A. F.
    Rybak-Feiglin, A.
    Cohn, D.
    DaSilva, C. A.
    Massaad, R.
    Santora, A. C.
    Scott, B. B.
    Kaufman, K. D.
    Verbruggen, N.
    Leung, A.
    Lombardi, A.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S35 - S36
12345